Home » Authors » Anette Breindl

Articles by Anette Breindl

Increasing Insulin Degradation Might Help Alzheimer's Patients

Dec. 27, 2004

By Anette Breindl

Increasing Insulin Degradation Might Help Alzheimer's Patients

Dec. 27, 2004

By Anette Breindl

Receptors, Signal Transduction Determine Range Of Viral Host

Dec. 22, 2004

By Anette Breindl

Receptors, Signal Transduction Determine Range Of Viral Host

Dec. 22, 2004

By Anette Breindl

New Contributor To Depression's Genetic Basis: SSRI Sensitivity

Dec. 20, 2004

By Anette Breindl

New Contributor To Depression's Genetic Basis: SSRI Sensitivity

Dec. 20, 2004

By Anette Breindl

Cutting Off TB's Energy Source Might Be Novel Line Of Attack

Dec. 15, 2004

By Anette Breindl

Cutting Off TB's Energy Source Might Be Novel Line Of Attack

Dec. 15, 2004

By Anette Breindl

Broadening Immune System's Horizon For New HIV Defenses

Dec. 13, 2004

By Anette Breindl

Broadening Immune System's Horizon For New HIV Defenses

Dec. 13, 2004

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...